Singapore: US-based Amgen is going to enter into a joint venture with Chinese pharmaceutical firm Zhejiang Beta Pharma, in which Amgen will own 49 percent of interest. The new firm will be named Amgen-Beta Pharmaceuticals and will help... Read more
Singapore: Malaysia-based Pharmaniaga has entered into a collaboration with Saudi Arabia-based Modern Healthcare Solutions... Read more
Singapore: US-based Actavis entered into a definitive agreement to acquire Dublin-based Warner Chilcott in a stock-for-stock... Read more
The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the US. Although it... Read more
Singapore: Takeda Pharmaceutical and H Lundbeck will be presenting new data from four studies that evaluated effectiveness in treating the... Read more
Singapore: Israel-based Oramed Pharmaceuticals received approval from the US FDA for its Investigational New Drug Application (INDA) for... Read more
Singapore: Bayer HealthCare, the University of California (UC), and seed-stage funding firm Mission Bay Capital have signed a three-year... Read more
The Indian pharmaceutical industry has witnessed a healthy growth in the last decade, driven by factors like rising consumption levels in... Read more
Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal... Read more
Singapore: Bausch + Lomb appointed Ms Maria Teresa Hilado to its board of directors. Ms Hilado is currently senior vice president of finance... Read more
Singapore: Bio Taiwan 2013, Taiwan's largest annual biotech event, which is to be held at TWTC Nangang Exhibition Center in Taipei from... Read more
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted, oral inhibitor... Read more
Survey Box